Professor Cristobal Dos Remedios
F13 - Anderson Stuart Building
On this page
Molecular basis of human heart failure
PhD and Masters' project opportunities
United States. (Harvard Medical School) working with Prof Paul Allen.
United States. (William Pu, PhD Department of Cardiology, Children''s Hospital Enders 13,300 Longwood Ave., Boston, MA 02115) Research collaboration involving the role of splicing variants of cardiac proteins in human heart failure.
United Kingdom. (Dr Michael Gray, Epithelial Research Group, Institute for Cell and Molecular Biosciences, University Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH) Research collaboration involving the role of a protein kinase called sgk1 in human heart failure..
United Kingdom. (Paul Riley PhD, Molecular Medicine Unit, UCL-Institute of Child Health, 30 Guilford Street, London, WC1N 1EH) Research collaboration involving hypertrophic cardiomyopathy (HOCM) myectomy heart samples to study transcriptional/microRNA regulation of sarcomeric gene expression in human heart failure..
United Kingdom. (Elizabeth Ehler PhD., Kings College London BHF Research Excellence Centre, The Randall Division of Cell and Molecular Biophysics, New Hunts House, Guys Campus, London SE1 1UL) Research collaboration involving measurement of expression levels of a muscle-specific isoform of the formin (FHOD3) in the human heart and its role in myofibril maintenance.
Japan. (Shin''ichi Ishiwata, Ph.D., Professor of Biophysics, Department of Physics, School of Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo, 169-8555) Awarded a JSRS Travel grant to visit in September 2008. In 2009 we commenced a collaborative, working on SPontaneous Oscilatory Contractions (SPOCs) as a method of quantifying functional deficits in end-stage failing human cardiomyocytes..
United Kingdom. (Ayesha De Souza, PhD, Department of Cardiac & Vascular Sciences, St. George''s Hospital, University of London, Cranmer Terrace Tooting, London, SW17 0RE) Research collaboration involving proteomic and metabolomic analysis of failing human left atria to reveal the molecular mechanism underlying atrial fibrillation..
United States. (Lilehei Heart Inst, Division of Cardiology, University of Minnesota) Collaboration with Prof Jennifer Hall working on transcriptomics of failing human hearts.
United Kingdom. (Jonathan C. Kentish, MA, PhD Cardiovascular Division,King''s College London Rayne Institute, St. Thomas''s Hospital, London SE1 7EH) Collaborating involving a study of normal passive viscoelasticity but abnormal myofibrillar contractile function in patients with obstructive hypertrophic cardiomyopathy..
United States. (Johns Hopkins University Medical School, Division of Cardiology, Biological Chemistry and Biomedical Engineering) Working with Prof Jennifer Van Eyk on proteomics of failing human hearts.
Ireland. (Michael J. Dunn, PhD, UCD Conway Institute of Biomolecular and Biomedical Research, School of Medicine and Medical Science, University College Dublin, Dublin 4) Research collaboration involving the protective effect of phosphorylated Hsp27 in human coronary arteries through actin stabilisation.
United States. (Harvard Children's Hospital, Cardiology) Collaboration with Dr Bill Pu working on microRNAs and human heart failure.
France. (Inserm U915, Institut du Thorax, Nantes Faculte de Medecine) Research collaboration between Dr Marja Steenman, my laboratory and a graduate student, Maurizio Stefani..
United States. (Bernhard Kuhn, MD, PhD, Harvard Children''s Hospital, 61 Binney Street, Enders 1329, Boston MA 02115) Research collaboration with this laboratory involving a study of growth, proliferation and regeneration in the human heart from infancy to senescence..
Netherlands. (Institute for Cardiovascular Research. Free University Amsterdam) Collaboration with Jolanda Van Der Velden and others in her laboratory.
United States. (Director, Long QT Syndrome Clinic and Windland Smith Rice Sudden Death Genomics Laboratory Mayo Clinic) Research collaboration into molecular changes in hypertrophic cardiomyopathy in human hearts.
China. (Professor Xiyun Yan, National Key Laboratory of Biomolecules,Institute of Biophysics, Chinese Academy of Sciences Datun Road No.15, Beijing 100101) Research collaboration involving the use of a monoclonal anti-CD146 antibody to identify the role of CD146 in human heart failure..
Sweden. (University of Uppsala, HPR Research Group, Rudbeck Laboratory, Dag Hammarskjold 20 S-751-85, Uppsala) Research collaboration with Prof Fredrik Ponten involving the use of tissue microarrays of failing and non-failing human hearts..
Netherlands. (D.Dooijes, PhD., Clinical Molecular Geneticist Department of of Clinical Genetics, Erasmus Medical College, Dr. Molewaterplein 50, 3015GE, ROTTERDAM) Collaboration involving the genotyping og familial heart failure in man..
Ireland. (University College Dublin) Working with Prof. Michael Dunn.
Germany. (Dr. Wolfgang A. Linke, Department of Cardiovascular Physiology, Institute of Physiology, Faculty of Medicine Ruhr University Bochum. D-44780 Bochum) Collaboration with Dr Wolfgang Linke on the role of protein kinase G in modulating the passive stiffness of phosphorylated titin, a giant protein component of the cardiomyocyte..
United States. (Anne M. Murphy MD, The Johns Hopkins University Medical School, 720 Rutland Avenue Ross Bldg. 1144, Baltimore, MD 21205) Research collaboration involving mutations in cardiac troponin I in failing and non-failing human left ventricles..
United Kingdom. (Imperial College London) Collaborating with Prof Steve Marston on molecular defects in failing human cardiac proteins, particularly the proteins that regulate contraction in the heart..